TELA Bio (TELA) Shares Outstanding (Weighted Average) (2018 - 2026)

TELA Bio's Shares Outstanding (Weighted Average) history runs 9 years deep, the most recent figure standing at $57.3 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 872.34% year-over-year to $57.3 million; the TTM figure through Mar 2026 stood at $57.3 million (up 872.34% YoY), while the FY2025 annual figure was $14.7 million, down 48.43% from the prior year.
• Shares Outstanding (Weighted Average) was $57.3 million for Q1 2026 at TELA Bio, up from $14.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $57.3 million in Q1 2026 to a low of $88556.0 in Q2 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $14.4 million across 5 years, with a median of $5.9 million in 2025.
• Biggest YoY gain for Shares Outstanding (Weighted Average) was 27547.66% in 2023; the steepest drop was 99.39% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $88556.0 in 2022, then jumped by 25723.96% to $22.9 million in 2023, then advanced by 24.74% to $28.5 million in 2024, then plunged by 48.43% to $14.7 million in 2025, then jumped by 289.19% to $57.3 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $57.3 million (Q1 2026), $14.7 million (Q4 2025), and $45.4 million (Q3 2025), per Business Quant data.